SGLT2 inhibitors for the composite of cardiorenal outcome in patients with chronic kidney disease: A systematic review and meta-analysis of randomized controlled trials
Hai‐Bin Chen, Yao‐Lin Yang, Tian-Hao Yu, Yuhui Li
Topics & Concepts
CanagliflozinDapagliflozinMedicineKidney diseaseInternal medicineRandomized controlled trialMeta-analysisRenal functionPlaceboClinical trialLinagliptinDiabetes mellitusIntensive care medicineType 2 diabetesEndocrinologyPathologyAlternative medicineDiabetes Treatment and ManagementPancreatic function and diabetesPancreatitis Pathology and Treatment